Genovis’ project for automatic analysis with the FabRICATOR® enzyme shows proof-of-concept
Genovis’ project to develop automated analysis solutions together with researchers from Lund Institute of Technology has reached the proof-of-concept stage, which now must be verified by a number of major industrial players.
“The results are important for Genovis since they clearly show commercial potential for FabRICATOR® (IdeS) in integrated analysis systems. It is mainly in quality control in the development and production of biopharmaceuticals that the system offers major advantages over current methods. We can see that in the long run this will open up a new market for Genovis’ FabRICATOR® enzyme,” says Sarah Fredriksson, CEO.
